Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG

Justin M. Roberts(Baylor College of Medicine), Nancy L. Weigel(Baylor College of Medicine), Rebeca San Martin(University of Tennessee at Knoxville), Jeffery A. Dodge(Eli Lilly (United States)), Danthasinghe Waduge Badrajee Piyarathna(Baylor College of Medicine), Cristian Coarfa(Baylor College of Medicine), Venkatesh Krishnan(Eli Lilly (United States)), David R. Rowley(Baylor College of Medicine), Guilherme V. Rocha(Eli Lilly (United States)), James G. MacKrell(University of Michigan–Ann Arbor)
Oncotarget
May 18, 2017
Cited by 2


Related Papers